LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation.
about
LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
LB-100, a novel Protein Phosph ...... rapeutic effects of radiation.
@en
LB-100, a novel Protein Phosph ...... rapeutic effects of radiation.
@nl
type
label
LB-100, a novel Protein Phosph ...... rapeutic effects of radiation.
@en
LB-100, a novel Protein Phosph ...... rapeutic effects of radiation.
@nl
prefLabel
LB-100, a novel Protein Phosph ...... rapeutic effects of radiation.
@en
LB-100, a novel Protein Phosph ...... rapeutic effects of radiation.
@nl
P2093
P2860
P1433
P1476
LB-100, a novel Protein Phosph ...... rapeutic effects of radiation.
@en
P2093
Anita Tandle
Ashlee Seldomridge
Deric M Park
Dragan Maric
John D Heiss
Kevin Camphausen
Mark R Gilbert
Saman Sizdahkhani
P2860
P356
10.1016/J.CANLET.2017.11.035
P407
P577
2017-11-30T00:00:00Z